81 related articles for article (PubMed ID: 19778787)
1. [Serum proteomic analysis on metastasis-associated proteins of hepatocellular carcinoma].
Fu BS; Liu W; Zhang JW; Zhang T; Li H; Chen GH
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Sep; 29(9):1775-8. PubMed ID: 19778787
[TBL] [Abstract][Full Text] [Related]
2. [The screening and identification of Apolipoprotein A-II from serum differential proteins in hepatocellular carcinoma patients].
Jiang ZH; Zhang ZY; He M; Qin J; Wang Q; Wei X; Nong BJ; Liu F
Zhonghua Gan Zang Bing Za Zhi; 2010 Jun; 18(6):445-9. PubMed ID: 20587316
[TBL] [Abstract][Full Text] [Related]
3. Inter-alpha Inhibitor H4 as a Potential Biomarker Predicting the Treatment Outcomes in Patients with Hepatocellular Carcinoma.
Lee EJ; Yang SH; Kim KJ; Cha H; Lee SJ; Kim JH; Song J; Chun KH; Seong J
Cancer Res Treat; 2018 Jul; 50(3):646-657. PubMed ID: 28724284
[TBL] [Abstract][Full Text] [Related]
4. Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values.
Luk JM; Lam CT; Siu AF; Lam BY; Ng IO; Hu MY; Che CM; Fan ST
Proteomics; 2006 Feb; 6(3):1049-57. PubMed ID: 16400691
[TBL] [Abstract][Full Text] [Related]
5. Glutamine synthetase as an early marker for hepatocellular carcinoma based on proteomic analysis of resected small hepatocellular carcinomas.
Long J; Lang ZW; Wang HG; Wang TL; Wang BE; Liu SQ
Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):296-305. PubMed ID: 20525558
[TBL] [Abstract][Full Text] [Related]
6. [Relationship of extrahepatic metastasis of primary hepatocellular carcinoma between circulative tumor cells in the blood of hepatoma patients].
Zhang GQ; Wang HB; Gao P; Fang CH; Chen GH
Zhonghua Wai Ke Za Zhi; 2009 Dec; 47(24):1857-9. PubMed ID: 20193401
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma.
Zhao J; Hu J; Cai J; Yang X; Yang Z
Chin Med J (Engl); 2003 May; 116(5):772-6. PubMed ID: 12875699
[TBL] [Abstract][Full Text] [Related]
8. [Expression of HIF-1alpha in serum of primary hepatocellular carcinoma and effects on tumor invasion and metastasis].
Zhang DH; Zhu WG; Yue S
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 May; 27(5):551-2, 554. PubMed ID: 21796840
[TBL] [Abstract][Full Text] [Related]
9. Proteomics of hepatocellular carcinoma: serum vimentin as a surrogate marker for small tumors (Sun S; Poon RT; Lee NP; Yeung C; Chan KL; Ng IO; Day PJ; Luk JM
J Proteome Res; 2010 Apr; 9(4):1923-30. PubMed ID: 20121168
[TBL] [Abstract][Full Text] [Related]
10. [Significance of vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma].
Zhao J; Hu J; Cai J
Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):389-92. PubMed ID: 11810769
[TBL] [Abstract][Full Text] [Related]
11. [The detection of circulating hepatocellular carcinoma cells in peripheral venous blood by reverse transcription-polymerase chain reaction and its clinical significance].
Liu Y; Zhang B; Qian G; Chen H; Wu M; Fu J; Huang C
Zhonghua Wai Ke Za Zhi; 1998 Oct; 36(10):608-10. PubMed ID: 11825477
[TBL] [Abstract][Full Text] [Related]
12. Toward the proteomic identification of biomarkers for the prediction of HBV related hepatocellular carcinoma.
He QY; Zhu R; Lei T; Ng MY; Luk JM; Sham P; Lau GK; Chiu JF
J Cell Biochem; 2008 Feb; 103(3):740-52. PubMed ID: 17557278
[TBL] [Abstract][Full Text] [Related]
13. KAI1, a new metastasis suppressor gene, is reduced in metastatic hepatocellular carcinoma.
Guo XZ; Friess H; Di Mola FF; Heinicke JM; Abou-Shady M; Graber HU; Baer HU; Zimmermann A; Korc M; Büchler MW
Hepatology; 1998 Dec; 28(6):1481-8. PubMed ID: 9828210
[TBL] [Abstract][Full Text] [Related]
14. [Study on the relationship between serum cytokeratin 19 level in hepatocellular carcinoma patients and the clinico-pathologic characteristics].
Li Y; Tang ZY; Tian B; Qin LX; Ye SL; Sun RX
Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):341-2. PubMed ID: 15225427
[TBL] [Abstract][Full Text] [Related]
15. [The influence of tumor cells spreading in blood to relapse and distant metastasis of hepatocellular carcinoma after surgery].
LIU Y; ZHANG GT; WU MC
Zhonghua Wai Ke Za Zhi; 2008 Oct; 46(20):1583-5. PubMed ID: 19094658
[TBL] [Abstract][Full Text] [Related]
16. Serum vascular endothelial growth factor is a predictor of invasion and metastasis in hepatocellular carcinoma.
Li XM; Tang ZY; Qin LX; Zhou J; Sun HC
J Exp Clin Cancer Res; 1999 Dec; 18(4):511-7. PubMed ID: 10746978
[TBL] [Abstract][Full Text] [Related]
17. [Expression of ESM-1 in hepatocellular carcinoma is associated with angiogenesis and tumor invasion].
Xiang X; Zhao WB; Wang X
Zhonghua Gan Zang Bing Za Zhi; 2009 Sep; 17(9):661-4. PubMed ID: 19785952
[TBL] [Abstract][Full Text] [Related]
18. [The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma].
Liu Y; Chen X; Peng S; Fang H; Wu Y; Peng C; Shi L; Bai M; Xu B; Wang J; Deng G
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1553-6. PubMed ID: 12609066
[TBL] [Abstract][Full Text] [Related]
19. [Proteomic analysis on metastasis-associated proteins of hepatocellular carcinoma tissues].
Song HY; Liu YK; Cui JF; Zhang LJ; Dai Z; Feng JT; Feng JX; Shen HL; Yang PY
Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):331-4. PubMed ID: 15918964
[TBL] [Abstract][Full Text] [Related]
20. [Osteopontin as a potential biomarker of metastasis and recurrence for hepatocellular carcinoma].
Cui BK; Zhang CQ; Zhang Y; Yuan YF; Zhang YQ; Shi M; Chen MS; Li SP; Li JQ
Ai Zheng; 2006 Jul; 25(7):876-9. PubMed ID: 16831281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
